Cancers

Papers
(The H4-Index of Cancers is 88. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-05-01 to 2024-05-01.)
ArticleCitations
Breast Cancer—Epidemiology, Risk Factors, Classification, Prognostic Markers, and Current Treatment Strategies—An Updated Review478
A Review of Colorectal Cancer in Terms of Epidemiology, Risk Factors, Development, Symptoms and Diagnosis313
Coumarins and Coumarin-Related Compounds in Pharmacotherapy of Cancer248
MHC Class I Downregulation in Cancer: Underlying Mechanisms and Potential Targets for Cancer Immunotherapy224
The CCL5/CCR5 Axis in Cancer Progression208
Colorectal Cancer: A Review of Carcinogenesis, Global Epidemiology, Current Challenges, Risk Factors, Preventive and Treatment Strategies202
Molecular Biology of Osteosarcoma196
Organoid and Spheroid Tumor Models: Techniques and Applications194
STING Agonists as Cancer Therapeutics189
CA125 and Ovarian Cancer: A Comprehensive Review187
The Role of the Gut Microbiome in Colorectal Cancer Development and Therapy Response185
Recent Advances in Zinc Oxide Nanoparticles (ZnO NPs) for Cancer Diagnosis, Target Drug Delivery, and Treatment177
Perspectives on Triple-Negative Breast Cancer: Current Treatment Strategies, Unmet Needs, and Potential Targets for Future Therapies174
PD-L1, TMB, MSI, and Other Predictors of Response to Immune Checkpoint Inhibitors in Biliary Tract Cancer162
The Warburg Effect 97 Years after Its Discovery158
Epidemiology of Glioblastoma Multiforme–Literature Review157
Immune Checkpoint Inhibitors for the Treatment of Bladder Cancer157
The Role of Macrophages in Cancer Development and Therapy155
EGFR in Cancer: Signaling Mechanisms, Drugs, and Acquired Resistance154
The Role of Tumor Microenvironment in Cancer Metastasis: Molecular Mechanisms and Therapeutic Opportunities151
Vimentin Is at the Heart of Epithelial Mesenchymal Transition (EMT) Mediated Metastasis150
Single-Cell Transcriptomic Analysis of Tumor-Derived Fibroblasts and Normal Tissue-Resident Fibroblasts Reveals Fibroblast Heterogeneity in Breast Cancer150
A Comprehensive Review of Cancer MicroRNA Therapeutic Delivery Strategies148
Interleukin-1β and Cancer148
Photodynamic Therapy: A Compendium of Latest Reviews143
Combined PARP Inhibition and Immune Checkpoint Therapy in Solid Tumors141
Senescence and Cancer: A Review of Clinical Implications of Senescence and Senotherapies139
Mechanisms of Cisplatin-Induced Acute Kidney Injury: Pathological Mechanisms, Pharmacological Interventions, and Genetic Mitigations136
Novel Transfer Learning Approach for Medical Imaging with Limited Labeled Data131
IL-12 Family Cytokines in Cancer and Immunotherapy131
Cannabidiol (CBD) as a Promising Anti-Cancer Drug129
Talimogene Laherparepvec (T-VEC): An Intralesional Cancer Immunotherapy for Advanced Melanoma129
The Pathogenic Role of PI3K/AKT Pathway in Cancer Onset and Drug Resistance: An Updated Review128
Circulating Tumor Cell Detection Technologies and Clinical Utility: Challenges and Opportunities126
Apoptosis Deregulation and the Development of Cancer Multi-Drug Resistance125
DNA Methyltransferases in Cancer: Biology, Paradox, Aberrations, and Targeted Therapy123
The Multifaceted Roles of Copper in Cancer: A Trace Metal Element with Dysregulated Metabolism, but Also a Target or a Bullet for Therapy122
HER2-Low Breast Cancer: Molecular Characteristics and Prognosis117
The Role of p53 Signaling in Colorectal Cancer114
Anti-Cancer Potential of Cannabinoids, Terpenes, and Flavonoids Present in Cannabis114
Lactate in the Tumor Microenvironment: An Essential Molecule in Cancer Progression and Treatment113
Carbon Ion Radiobiology113
Global Burden, Risk Factors, and Trends of Esophageal Cancer: An Analysis of Cancer Registries from 48 Countries113
Targeting Glucose Metabolism to Overcome Resistance to Anticancer Chemotherapy in Breast Cancer111
Molecular Bases of Drug Resistance in Hepatocellular Carcinoma111
Three-Dimensional Culture System of Cancer Cells Combined with Biomaterials for Drug Screening111
FLASH Proton Pencil Beam Scanning Irradiation Minimizes Radiation-Induced Leg Contracture and Skin Toxicity in Mice109
Application of Artificial Intelligence Technology in Oncology: Towards the Establishment of Precision Medicine108
Targeting Multiple Signaling Pathways in Cancer: The Rutin Therapeutic Approach108
Flavonoids in Cancer Metastasis107
Non-Invasive Biomarkers for Early Detection of Breast Cancer107
MAPK/ERK Signaling Pathway in Hepatocellular Carcinoma107
Breast Cancer—Epidemiology, Classification, Pathogenesis and Treatment (Review of Literature)106
Recurrent Glioblastoma: From Molecular Landscape to New Treatment Perspectives106
Extracellular Glutathione Peroxidase GPx3 and Its Role in Cancer105
A Review of Circulating Tumour Cell Enrichment Technologies104
The Role of Tumor Microenvironment in Multiple Myeloma Development and Progression104
The Role of Probiotics in Cancer Prevention103
The Role of Cancer-Associated Fibroblasts in Cancer Invasion and Metastasis103
Tumor-Associated Macrophage Status in Cancer Treatment102
The Role of Cancer-Associated Fibroblasts in Tumor Progression102
Epigenetic Associations between lncRNA/circRNA and miRNA in Hepatocellular Carcinoma102
Chemotherapy Side-Effects: Not All DNA Damage Is Equal101
The Role of Oxidative Stress and Its Counteractive Utility in Colorectal Cancer (CRC)101
Gold Nanoparticles as a Potent Radiosensitizer: A Transdisciplinary Approach from Physics to Patient100
The KEAP1–NRF2 System as a Molecular Target of Cancer Treatment99
Copper Complexes as Anticancer Agents Targeting Topoisomerases I and II99
Overcoming Platinum and PARP-Inhibitor Resistance in Ovarian Cancer98
RGD-Binding Integrins Revisited: How Recently Discovered Functions and Novel Synthetic Ligands (Re-)Shape an Ever-Evolving Field98
Emerging Therapies for Hepatocellular Carcinoma (HCC)97
Anticancer Therapy with HDAC Inhibitors: Mechanism-Based Combination Strategies and Future Perspectives97
Immune Escape Mechanisms in Non Small Cell Lung Cancer95
CTLA-4 in Regulatory T Cells for Cancer Immunotherapy93
Targeting BCL-2 in Cancer: Advances, Challenges, and Perspectives93
Mechanisms of Taxane Resistance92
Arginine Signaling and Cancer Metabolism92
Neutrophil Extracellular Traps (NETs) in Cancer Invasion, Evasion and Metastasis91
Breast and Gut Microbiota Action Mechanisms in Breast Cancer Pathogenesis and Treatment91
Impact of the COVID-19 Pandemic on Cancer Diagnoses in General and Specialized Practices in Germany91
Current Landscape of Non-Small Cell Lung Cancer: Epidemiology, Histological Classification, Targeted Therapies, and Immunotherapy90
Mechanisms of Long Non-Coding RNAs in Cancers and Their Dynamic Regulations89
The Functional Crosstalk between Myeloid-Derived Suppressor Cells and Regulatory T Cells within the Immunosuppressive Tumor Microenvironment89
Sorafenib Resistance in Hepatocellular Carcinoma: The Relevance of Genetic Heterogeneity89
Oral–Gut Microbiome Axis in Gastrointestinal Disease and Cancer89
Lipid Metabolism in Development and Progression of Hepatocellular Carcinoma89
Stimuli-Responsive Hydrogels for Cancer Treatment: The Role of pH, Light, Ionic Strength and Magnetic Field88
Surgical Management of the Axilla in Clinically Node-Positive Breast Cancer Patients Converting to Clinical Node Negativity through Neoadjuvant Chemotherapy: Current Status, Knowledge Gaps, and Ration88
Immunotherapy for Hepatocellular Carcinoma: A 2021 Update88
0.052135229110718